The inpatient burden of psoriasis in the United States

Abstract

There are racial and health care disparities in hospitalization for psoriasis, stressing the need for improved access to dermatologic care for all patients.

Inpatient Financial Burden of Atopic Dermatitis in the United States

“…The prevalence of hospitalization with a primary diagnosis of AD-E increased in adults between 2002 and 2012, compared with stable or decreasing rates of hospitalization previously observed in psoriasis (Hsu et al, 2016b) and pemphigus (Hsu et al, 2015), respectively. Mean inpatient costs per hospitalization for AD were only 60% and 33% of the costs per hospitalization for psoriasis or pemphigus (Hsu et al, 2015(Hsu et al, , 2016b. Lower costs per hospitalization for AD-E were due to 62.5% and 50% shorter LOS than previously observed for pemphigus and psoriasis (Hsu et al, 2015(Hsu et al, , 2016b.…”

“…The present study demonstrates a considerable inpatient financial burden of AD in the United States. Between 2002 and 2012, the prevalence of hospitalization for AD-E was 2.4-and 5.6-fold higher than for psoriasis (Hsu et al, 2016b) and pemphigus (Hsu et al, 2015) during the same time period, respectively. The prevalence of hospitalization with a primary diagnosis of AD-E increased in adults between 2002 and 2012, compared with stable or decreasing rates of hospitalization previously observed in psoriasis (Hsu et al, 2016b) and pemphigus (Hsu et al, 2015), respectively.…”

“…Between 2002 and 2012, the prevalence of hospitalization for AD-E was 2.4-and 5.6-fold higher than for psoriasis (Hsu et al, 2016b) and pemphigus (Hsu et al, 2015) during the same time period, respectively. The prevalence of hospitalization with a primary diagnosis of AD-E increased in adults between 2002 and 2012, compared with stable or decreasing rates of hospitalization previously observed in psoriasis (Hsu et al, 2016b) and pemphigus (Hsu et al, 2015), respectively. Mean inpatient costs per hospitalization for AD were only 60% and 33% of the costs per hospitalization for psoriasis or pemphigus (Hsu et al, 2015(Hsu et al, , 2016b.…”

Predictors of Hospitalization, Length of Stay, and Cost of Care Among Adults With Dermatomyositis in the United States

“…Decreased access to care and worse health outcomes have previously been observed in racial/ethnic minorities. In addition, racial/ethnic differences have been observed in hospitalization rates for other autoimmune and inflammatory disorders, such as pemphigus and psoriasis . Future studies are needed to determine how access to outpatient specialty care has affected the rate of hospitalization in patients with chronic diseases.…”

Trends in hospitalization rates for psoriasis flares since the introduction of biologics: a time series in France between 2005 and 2015

“…However, to the best of our knowledge, an association between the increased use of biologics and a fall in the number of hospitalizations for psoriasis flares has not been reported. We nevertheless assumed that the confirmed short‐, medium‐ and long‐term efficacy of biologics should be associated with a reduction over time in the hospitalization rate for psoriasis flares with discharge to ambulatory care . Thus, the objectives of this study were to (i) analyse the changes over time in the hospitalization rate for psoriasis flares between 2005 and 2015 in France, and (ii) determine whether the introduction of biologics was associated with a break point in this hospitalization rate.…”